Exane Derivatives’s ProShares Trust UltraShort Lehman 20+ Year Treasury TBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,500
Closed -$279K 1088
2021
Q4
$279K Hold
16,500
0.07% 273
2021
Q3
$303K Buy
+16,500
New +$289K 0.07% 285
2017
Q1
Sell
-3,431
Closed -$140K 674
2016
Q4
$140K Sell
3,431
-17,777
-84% -$671K 0.03% 223
2016
Q3
$670K Sell
21,208
-11,915
-36% -$373K 0.1% 135
2016
Q2
$1.05M Sell
33,123
-3,344
-9% -$119K 0.17% 85
2016
Q1
$1.34M Buy
36,467
+18,779
+106% +$727K 0.18% 76
2015
Q4
$779K Buy
17,688
+719
+4% +$31.6K 0.11% 93
2015
Q3
$736K Buy
16,969
+529
+3% +$24.2K 0.09% 103
2015
Q2
$819K Sell
16,440
-5,450
-25% -$255K 0.09% 108
2015
Q1
$917K Sell
21,890
-5,890
-21% -$251K 0.1% 101
2014
Q4
$1.29M Buy
+27,780
New +$1.42M 0.18% 89

Other funds holding TBT

Exane Derivatives's TBT Position: Q1 2022 in Review

Exane Derivatives sold out of ProShares Trust UltraShort Lehman 20+ Year Treasury (TBT) in Q1 2022, closing a stake of 16,500 shares — an estimated $279K sold.

Exane Derivatives first reported a position in TBT in Q4 2014 and held it in 11 quarters. The position peaked at $1.34M in Q1 2016. 108 funds tracked by Wall St. Rank hold TBT as of Q1 2022.

  • Exane Derivatives reported no remaining ProShares Trust UltraShort Lehman 20+ Year Treasury position as of Q1 2022 after selling out during the quarter.
  • Exane Derivatives sold 16,500 ProShares Trust UltraShort Lehman 20+ Year Treasury shares in Q1 2022, an estimated $279K.
  • Exane Derivatives first reported a position in ProShares Trust UltraShort Lehman 20+ Year Treasury in Q4 2014 and held it in 11 quarters.
  • Exane Derivatives's ProShares Trust UltraShort Lehman 20+ Year Treasury position peaked at $1.34M in Q1 2016.
  • 108 funds tracked by Wall St. Rank held ProShares Trust UltraShort Lehman 20+ Year Treasury as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.